Latest California Healthline Stories
A New Diagnosis: ‘Post-Election Stress Disorder’
Trump opponents — and even some supporters — say the election and tumultuous early days of the new administration have left them anxious, angry and afraid of Facebook.
An Alzheimer’s ‘Tsunami’ Threatens Latinos
The number of U.S. Latinos with the memory-robbing disease is expected to rise more than eightfold by 2060, to 3.5 million, according to a recent report — putting a strain on families and health care resources.
Travel Ban Spotlights U.S. Dependence On Foreign-Born Doctors
One in four doctors practicing in the U.S. is an international medical doctor. Many foreign-born doctors practice in parts of the country where there are doctor shortages.
Un ‘tsunami’ de Alzheimer amenaza a latinos
Según un informe reciente, se espera que el número de latinos en los Estados Unidos con la enfermedad roba-memoria aumente más de ocho veces para 2060, a 3,5 millones de casos, poniendo presión en las familias y en los recursos de salud.
How Long You Stay On Opioids May Depend On The Doctor You See In the E.R.
A study shows some emergency physicians wrote far more opioid prescriptions and Medicare patients who saw those doctors were more likely to still be taking the addictive painkillers months later.
Docs Bill Medicare For End-Of-Life Advice As ‘Death Panel’ Fears Reemerge
The federal program paid $16 million in the first six months of 2016 to counsel 223,000 patients about treatment preferences in their last days.
A Deep Dive Into 4 GOP Talking Points On Health Care
The president says Obamacare has been “a complete and total disaster,” and other Republicans see nothing but trouble. But a careful look at the arguments suggest the situation is more complicated.
Former FDA Chief Cites 5 Things To Watch On Drug Approvals, And Keeping Drugs Safe
Former FDA Commissioner Dr. Robert Califf shares his views about drug approvals, regulations and safety concerns after stepping down from the giant agency.
Drugmaker Marathon ‘Pausing’ Delivery Of $89,000-a-year Muscular Dystrophy Drug
After hearing complaints about its high price, Marathon Pharmaceuticals is pausing the launch of an $89,000 drug for a rare disease.
Obamacare Came To Montana Indian Country And Brought Jobs
In remote parts of Montana, the Affordable Care Act has meant better health care for Native Americans and more job opportunities.